ADVERTISEMENT

Relaxo Footwears Q2 Results Review - Margins Would Take Time To Normalise; Downgrade To 'Sell': Dolat Capital

Relaxo Footwears had taken ~15% price cuts during September 2022.

<div class="paragraphs"><p>Relaxo Footwear store. (Source: Company official fb page</p></div>
Relaxo Footwear store. (Source: Company official fb page
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit